HeartWare International Company Profile (NASDAQ:HTWR)

About HeartWare International (NASDAQ:HTWR)

HeartWare International logoHeartware International, Inc. is a medical device company. The Company develops and manufactures miniaturized implantable heart pumps or ventricular assist devices to treat patients suffering from advanced heart failure. The Company operates in the segment of design and manufacture of medical devices. The HeartWare Ventricular Assist System (HVAD System), which includes a ventricular assist device (VAD) or blood pump, patient accessories and surgical tools, provides circulatory support for patients in the advanced stage of heart failure. The HVAD System is designed to be implanted adjacent to the heart, avoiding abdominal surgery. The HVAD System features the centrifugal pump designed to be implanted in the chest, directly adjacent to the heart. It develops MVAD System, a miniaturized device. The CircuLite Surgical System is designed to be implanted through a right, mini-thoracotomy procedure and does not require a sternotomy or cardiopulmonary bypass.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Devices & Implants
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:HTWR
  • CUSIP: 42236810
  • Web: https://www.heartware.com/
Average Prices:
  • 50 Day Moving Avg: $57.82
  • 200 Day Moving Avg: $39.18
  • 52 Week Range: $25.02 - $87.38
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -22.83
  • P/E Growth: 0.00
Profitability:
  • Net Margins: -15.84%
  • Return on Equity: -25.32%
  • Return on Assets: -10.14%
Misc:
  • Average Volume: 540,875 shs.
  • Beta: 0.3
 
Frequently Asked Questions for HeartWare International (NASDAQ:HTWR)

What is HeartWare International's stock symbol?

HeartWare International trades on the NASDAQ under the ticker symbol "HTWR."

How were HeartWare International's earnings last quarter?

HeartWare International Inc (NASDAQ:HTWR) announced its earnings results on Thursday, July, 28th. The company reported ($0.43) earnings per share for the quarter, beating analysts' consensus estimates of ($0.82) by $0.39. The business earned $68.72 million during the quarter, compared to analyst estimates of $57.36 million. HeartWare International had a negative net margin of 15.84% and a negative return on equity of 25.32%. The company's quarterly revenue was down 6.6% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.47) EPS. View HeartWare International's Earnings History.

Where is HeartWare International's stock going? Where will HeartWare International's stock price be in 2017?

2 analysts have issued 12 month price targets for HeartWare International's stock. Their predictions range from $58.00 to $58.00. On average, they expect HeartWare International's stock price to reach $58.00 in the next year. View Analyst Ratings for HeartWare International.

Who are some of HeartWare International's key competitors?

How do I buy HeartWare International stock?

Shares of HeartWare International can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is HeartWare International's stock price today?

One share of HeartWare International stock can currently be purchased for approximately $57.98.


MarketBeat Community Rating for HeartWare International (NASDAQ HTWR)
Community Ranking:  2.8 out of 5 ( )
Outperform Votes:  323 (Vote Outperform)
Underperform Votes:  257 (Vote Underperform)
Total Votes:  580
MarketBeat's community ratings are surveys of what our community members think about HeartWare International and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for HeartWare International (NASDAQ:HTWR) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $58.00 (0.03% upside)

Analysts' Ratings History for HeartWare International (NASDAQ:HTWR)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/25/2016BTIG ResearchReiterated RatingHoldN/AView Rating Details
7/28/2016Canaccord GenuityReiterated RatingBuy$58.00N/AView Rating Details
7/13/2016Raymond James Financial, Inc.DowngradeOutperform -> Market PerformN/AView Rating Details
7/11/2016Leerink SwannDowngradeOutperform -> Market Perform$58.00N/AView Rating Details
6/29/2016Wells Fargo & CompanyDowngradeOutperform -> Market PerformN/AView Rating Details
6/29/2016Barclays PLCDowngradeOverweight -> Equal Weight$35.00 -> $58.00N/AView Rating Details
6/28/2016SunTrust Banks, Inc.DowngradeBuy -> Neutral$60.00 -> $58.00N/AView Rating Details
6/8/2016GuggenheimInitiated CoverageNeutralN/AView Rating Details
4/25/2016Bank of America CorporationReiterated RatingBuyN/AView Rating Details
2/27/2016Northland SecuritiesReiterated RatingHoldN/AView Rating Details
1/31/2016William BlairReiterated RatingMarket PerformN/AView Rating Details
1/13/2016Oppenheimer Holdings, Inc.Reiterated RatingMarket PerformN/AView Rating Details
1/12/2016Sterne Agee CRTReiterated RatingBuy$60.00 -> $55.00N/AView Rating Details
1/12/2016J P Morgan Chase & CoDowngradeOverweight -> Neutral$56.00 -> $39.00N/AView Rating Details
11/13/2015Goldman Sachs Group, Inc. (The)Boost Price Target$41.00 -> $45.00N/AView Rating Details
10/30/2015Piper Jaffray CompaniesDowngradeOverweight -> Neutral$48.00 -> $44.00N/AView Rating Details
10/28/2015Credit Suisse GroupBoost Price Target$34.00 -> $48.00N/AView Rating Details
10/2/2015Capital Ideas ResearchUpgradeUnderperform -> MarketperformN/AView Rating Details
(Data available from 7/26/2015 forward)

Earnings

Earnings History for HeartWare International (NASDAQ:HTWR)
Earnings by Quarter for HeartWare International (NASDAQ:HTWR)
Earnings History by Quarter for HeartWare International (NASDAQ HTWR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/28/2016Q2($0.82)($0.43)$57.36 million$68.72 millionViewN/AView Earnings Details
5/4/2016Q116($0.79)($0.95)$60.07 million$55.10 millionViewListenView Earnings Details
2/25/2016Q415($0.74)($0.53)$67.87 million$68.10 millionViewListenView Earnings Details
10/29/2015Q315($0.53)($1.36)$67.54 million$65.20 millionViewListenView Earnings Details
7/30/2015Q215($0.49)($0.47)$72.08 million$73.60 millionViewListenView Earnings Details
4/30/2015Q115($0.57)($0.55)$73.38 million$70.00 millionViewListenView Earnings Details
2/26/2015Q414($0.55)($0.41)$72.10 million$72.20 millionViewListenView Earnings Details
10/30/2014Q3($0.66)($0.64)$69.30 million$68.60 millionViewListenView Earnings Details
7/31/2014Q2($0.71)($0.29)$67.01 million$70.10 millionViewListenView Earnings Details
5/1/2014Q1($0.86)($0.70)$59.03 million$66.47 millionViewListenView Earnings Details
2/27/2014Q4($0.79)($0.92)$55.92 million$53.10 millionViewListenView Earnings Details
8/8/2013Q2 2013($0.73)($0.79)ViewListenView Earnings Details
2/27/2013Q4 2012($1.64)($1.46)$30.92 million$32.66 millionViewListenView Earnings Details
11/9/2012Q312($1.54)($1.75)$26.09 million$22.90 millionViewN/AView Earnings Details
8/4/2011($0.62)($0.73)ViewN/AView Earnings Details
5/5/2011($0.62)($0.68)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for HeartWare International (NASDAQ:HTWR)
2017 EPS Consensus Estimate: ($2.51)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172($0.75)($0.40)($0.58)
Q2 20171($0.79)($0.79)($0.79)
Q3 20172($0.71)($0.42)($0.57)
Q4 20171($0.58)($0.58)($0.58)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for HeartWare International (NASDAQ:HTWR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for HeartWare International (NASDAQ:HTWR)
Insider Trades by Quarter for HeartWare International (NASDAQ:HTWR)
Institutional Ownership by Quarter for HeartWare International (NASDAQ:HTWR)
Insider Trades by Quarter for HeartWare International (NASDAQ:HTWR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/22/2016Mark StrongVPSell1,875$57.71$108,206.25View SEC Filing  
7/11/2016Peter F McareeCFOSell3,125$57.68$180,250.00View SEC Filing  
7/1/2016James SchuermannSVPSell1,000$57.77$57,770.00View SEC Filing  
4/1/2016James SchuermannSVPSell1,000$31.36$31,360.00View SEC Filing  
2/29/2016Stephen N OesterleDirectorBuy1,000$32.17$32,170.00View SEC Filing  
2/25/2016Douglas Evan GodshallInsiderSell1,990$29.20$58,108.00View SEC Filing  
2/25/2016James SchuermannSVPSell601$29.24$17,573.24View SEC Filing  
2/25/2016Lawrence J KnopfGeneral CounselSell423$29.16$12,334.68View SEC Filing  
2/25/2016Mark StrongVPSell395$29.68$11,723.60View SEC Filing  
2/25/2016Peter F McareeCFOSell697$29.01$20,219.97View SEC Filing  
2/24/2016Douglas Evan GodshallInsiderSell1,153$32.35$37,299.55View SEC Filing  
2/24/2016Lawrence J KnopfGeneral CounselSell287$32.27$9,261.49View SEC Filing  
2/24/2016Mark StrongVPSell750$32.34$24,255.00View SEC Filing  
2/24/2016Peter F McareeCFOSell438$32.38$14,182.44View SEC Filing  
2/8/2016Douglas Evan GodshallinsiderSell1,796$36.58$65,697.68View SEC Filing  
2/8/2016James SchuermannSVPSell647$36.77$23,790.19View SEC Filing  
2/8/2016Lawrence J. KnopfGeneral CounselSell568$36.49$20,726.32View SEC Filing  
2/8/2016Peter F. McareeCFOSell700$36.85$25,795.00View SEC Filing  
12/22/2015Douglas Evan GodshallinsiderSell4,324$46.30$200,201.20View SEC Filing  
12/22/2015James SchuermannSVPSell1,202$46.39$55,760.78View SEC Filing  
12/22/2015Lawrence J. KnopfGeneral CounselSell721$46.44$33,483.24View SEC Filing  
12/21/2015James SchuermannSVPSell553$46.54$25,736.62View SEC Filing  
10/1/2015James SchuermannSVPSell1,000$53.01$53,010.00View SEC Filing  
10/1/2015Mark StrongVPSell2,625$52.55$137,943.75View SEC Filing  
8/26/2015Katrin LeadleyinsiderSell3,750$80.02$300,075.00View SEC Filing  
7/22/2015Mark StrongVPSell1,875$88.06$165,112.50View SEC Filing  
7/10/2015Peter F McareeCFOSell3,125$73.36$229,250.00View SEC Filing  
7/1/2015James SchuermannSVPSell1,000$72.78$72,780.00View SEC Filing  
4/21/2015Adage Capital Partners Gp LlcMajor ShareholderSell173,267$80.70$13,982,646.90View SEC Filing  
4/1/2015James SchuermannSVPSell1,000$86.34$86,340.00View SEC Filing  
3/30/2015Lawrence J KnopfGeneral CounselSell1,741$88.81$154,618.21View SEC Filing  
2/25/2015Douglas Evan GodshallInsiderSell1,842$89.58$165,006.36View SEC Filing  
2/9/2015Douglas Evan GodshallInsiderSell1,698$86.58$147,012.84View SEC Filing  
1/2/2015James SchuermannSVPSell1,429$72.69$103,874.01View SEC Filing  
12/22/2014James SchuermannSVPSell2,421$73.00$176,733.00View SEC Filing  
12/22/2014Jeffrey LaroseInsiderSell3,072$72.98$224,194.56View SEC Filing  
12/1/2014James SchuermannSVPSell1,500$73.06$109,590.00View SEC Filing  
11/3/2014James SchuermannSVPSell1,500$76.36$114,540.00View SEC Filing  
10/1/2014Mark StrongVPSell2,625$76.96$202,020.00View SEC Filing  
9/15/2014Adage Capital Partners Gp LlcMajor ShareholderBuy100,000$76.94$7,694,000.00View SEC Filing  
9/15/2014Jeffrey LaroseInsiderBuy150$77.11$11,566.50View SEC Filing  
8/19/2014Jeffrey LaroseInsiderSell2,179$81.51$177,610.29View SEC Filing  
8/18/2014Robert Bain ThomasDirectorSell1,000$81.97$81,970.00View SEC Filing  
7/10/2014Peter F McareeCFOSell2,070$84.76$175,453.20View SEC Filing  
5/19/2014Robert Bain ThomasDirectorSell1,000$93.39$93,390.00View SEC Filing  
5/14/2014Robert Bain ThomasDirectorSell1,000$93.16$93,160.00View SEC Filing  
5/7/2014Robert Bain ThomasDirectorSell2,000$93.70$187,400.00View SEC Filing  
5/1/2014Jeffrey LaroseInsiderSell2,179$89.96$196,022.84View SEC Filing  
4/1/2014Jeffrey LaroseInsiderSell2,179$94.26$205,392.54View SEC Filing  
3/31/2014Lawrence KnopfGeneral CounselSell1,744$91.15$158,965.60View SEC Filing  
3/11/2014David HathawayInsiderSell4,413$95.00$419,235.00View SEC Filing  
3/3/2014Jeffrey LaroseInsiderSell2,179$93.15$202,973.85View SEC Filing  
2/10/2014Douglas Evan GodshallInsiderSell2,428$94.57$229,615.96View SEC Filing  
2/3/2014Jeffrey LaroseInsiderSell2,179$98.48$214,587.92View SEC Filing  
1/7/2014Jeffrey LaroseInsiderSell15,342$100.00$1,534,200.00View SEC Filing  
1/6/2014Seth Loring HarrisonDirectorSell7,909$99.29$785,284.61View SEC Filing  
1/2/2014Jeffrey LaroseInsiderSell2,179$92.82$202,254.78View SEC Filing  
12/23/2013Douglas Evan GodshallInsiderSell7,036$91.37$642,879.32View SEC Filing  
12/23/2013James SchuermannSVPSell2,609$91.41$238,488.69View SEC Filing  
12/4/2013Robert Bain ThomasDirectorSell2,500$95.54$238,850.00View SEC Filing  
12/2/2013Douglas Evan GodshallInsiderSell13,000$95.51$1,241,630.00View SEC Filing  
11/7/2013Douglas Evan GodshallInsiderSell8,000$83.06$664,480.00View SEC Filing  
10/14/2013Douglas Evan GodshallInsiderSell8,000$75.03$600,240.00View SEC Filing  
9/3/2013Douglas Evan GodshallInsiderSell8,000$78.08$624,640.00View SEC Filing  
8/1/2013James SchuermannSVPSell1,000$93.07$93,070.00View SEC Filing  
8/1/2013Jeffrey LaroseInsiderSell2,179$93.11$202,886.69View SEC Filing  
7/29/2013Douglas Evan GodshallInsiderSell33,000$92.95$3,067,350.00View SEC Filing  
7/10/2013Peter F McareeCFOSell2,950$93.58$276,061.00View SEC Filing  
7/1/2013Jeffrey LaroseInsiderSell2,179$95.85$208,857.15View SEC Filing  
7/1/2013Seth Loring HarrisonDirectorSell13,118$95.57$1,253,687.26View SEC Filing  
6/25/2013Robert E YocherSVPSell1,162$94.25$109,518.50View SEC Filing  
6/17/2013Jeffrey LaroseInsiderSell2,179$91.14$198,594.06View SEC Filing  
6/6/2013Robert Bain ThomasDirectorSell2,656$90.44$240,208.64View SEC Filing  
5/30/2013Robert Bain ThomasDirectorSell3,557$94.04$334,500.28View SEC Filing  
5/28/2013David R HathawayInsiderSell5,934$95.05$564,026.70View SEC Filing  
5/22/2013David R HathawayInsiderSell29,540$96.38$2,847,065.20View SEC Filing  
5/20/2013Denis Newell WadeDirectorSell4,000$99.00$396,000.00View SEC Filing  
5/20/2013Jeffrey LaroseInsiderSell9,574$97.79$936,241.46View SEC Filing  
5/20/2013Lawrence J KnopfGeneral CounselSell2,000$97.72$195,440.00View SEC Filing  
12/4/2012Robert Bain ThomasDirectorSell5,000$80.43$402,150.00View SEC Filing  
11/1/2012James SchuermannSVPSell1,000$84.01$84,010.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for HeartWare International (NASDAQ:HTWR)
Latest Headlines for HeartWare International (NASDAQ:HTWR)
Source:

Social

Chart

HeartWare International (HTWR) Chart for Wednesday, July, 26, 2017

This page was last updated on 7/26/2017 by MarketBeat.com Staff